Bing Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bing Wu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Fei Zheng
Department of Cardiology, and Institute of Clinical Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, People's Republic of China
1 shared publication - Jia-Ning Wang
Experimental Animal Center & Institute of Clinical Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, China
1 shared publication - Jian-Ye Yang
Institute of Clinical Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China
1 shared publication - Jun Wang
Department of Cardiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China
1 shared publication - Jun-Ming Tang
Department of Pharmacology; Hubei Key Laboratory of Embryonic Stem Cell Research; and Department of Geriatrics & General Medicine of Taihe Hospital, Hubei University of Medicine, Shiyan, China
1 shared publication - Lei Zhang
Department of Cardiology, and Institute of Clinical Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 13 April 2023
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-12
Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model
Background: The triglyceride glucose (TyG) index is a well-established biomarker for insulin resistance (IR) that shows correlation with poor outcomes in patients with coronary artery disease. We aimed to integrate the TyG index with clinical data in a prediction nomogram for the long-term prognosis of new onset ST-elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI) . Methods: This retrospective study included new-onset STEMI patients admitted at two heart centers for emergency PCI from December 2015 to March 2018 in development and independent validation cohorts. Potential risk factors were screened applying least absolute shrinkage and selection operator (LASSO) regression. Multiple Cox regression was employed to identify independent risk factors for prediction nomogram construction. Nomogram performance was assessed based on receiver operating characteristic curve analysis, calibration curves, Harrell’s C-index and decision curve analysis (DCA). Results: In total, 404 patients were assigned to the development cohort and 169 to the independent validation cohort. The constructed nomogram included four clinical variables: age, diabetes mellitus, current smoking, and TyG index. The Harrell’s C-index values for the nomogram were 0.772 (95% confidence interval [CI]: 0.721–0.823) in the development cohort and 0.736 (95%CI: 0.656–0.816) in the independent validation cohort. Significant correlation was found between the predicted and actual outcomes in both cohorts, indicating that the nomogram is well calibrated. DCA confirmed the clinical value of the development prediction nomogram. Conclusions: Our validated prediction nomogram based on the TyG index and electronic health records data was shown to provide accurate and reliable discrimination of new-onset STEMI patients at high- and low-risk for major adverse cardiac events at 2, 3 and 5 years following emergency PCI.
- 13 April 2023
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-12
Open AccessPredicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model
Background: The triglyceride glucose (TyG) index is a well-established biomarker for insulin resistance (IR) that shows correlation with poor outcomes in patients with coronary artery disease. We aimed to integrate the TyG index with clinical data in a prediction nomogram for the long-term prognosis of new onset ST-elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI) . Methods: This retrospective study included new-onset STEMI patients admitted at two heart centers for emergency PCI from December 2015 to March 2018 in development and independent validation cohorts. Potential risk factors were screened applying least absolute shrinkage and selection operator (LASSO) regression. Multiple Cox regression was employed to identify independent risk factors for prediction nomogram construction. Nomogram performance was assessed based on receiver operating characteristic curve analysis, calibration curves, Harrell’s C-index and decision curve analysis (DCA). Results: In total, 404 patients were assigned to the development cohort and 169 to the independent validation cohort. The constructed nomogram included four clinical variables: age, diabetes mellitus, current smoking, and TyG index. The Harrell’s C-index values for the nomogram were 0.772 (95% confidence interval [CI]: 0.721–0.823) in the development cohort and 0.736 (95%CI: 0.656–0.816) in the independent validation cohort. Significant correlation was found between the predicted and actual outcomes in both cohorts, indicating that the nomogram is well calibrated. DCA confirmed the clinical value of the development prediction nomogram. Conclusions: Our validated prediction nomogram based on the TyG index and electronic health records data was shown to provide accurate and reliable discrimination of new-onset STEMI patients at high- and low-risk for major adverse cardiac events at 2, 3 and 5 years following emergency PCI.
- Open Access
- 1 February 2018
- Published by Elsevier in Data in Brief
- Vol. 16, 266-270
Data on the involvement of Meox1 in balloon-injury-induced neointima formation of rats
- 1 February 2018
- Published by Elsevier in Data in Brief
- Vol. 16, 266-270
Open AccessData on the involvement of Meox1 in balloon-injury-induced neointima formation of rats